Perflutren-Based Echocardiographic Contrast in Patients With Right-to-Left Intracardiac Shunts | Zendy

Ankur Kalra | Zendy; Gautam R. Shroff | Zendy; Darryl Erlien | Zendy; David T. Gilbertson | Zendy; Charles A. Herzog | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Perflutren-Based Echocardiographic Contrast in Patients With Right-to-Left Intracardiac Shunts

Author(s) -

Ankur Kalra,

Gautam R. Shroff,

Darryl Erlien,

David T. Gilbertson,

Charles A. Herzog

Publication year - 2014

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2013.11.003

Subject(s) - intracardiac injection , right to left , medicine , left and right , contrast (vision) , cardiology , right heart , radiology , computer science , artificial intelligence , engineering , structural engineering , operating system

Use of second-generation perflutren-based echocardiographic contrast agents (perflutren) is currently contraindicated in patients with known right-to-left, bidirectional, or transient right-to-left intracardiac shunts (intracardiac shunts) according to the U.S. Food and Drug Administration. This

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research